Cannabis Earnings Show How Verano and SNDL Are Navigating Margin Pressure, Pricing, and Uneven Demand

Recent results from Verano Holdings and SNDL Inc. illustrate how operator performance is shaped by geography, product mix, and execution, rather than broad industry growth.

Verano: Retail Strength Meets Margin Pressure

Verano reported first-quarter revenue of $208 million, roughly flat year over year but slightly higher sequentially, reflecting steady demand in key markets. Adjusted EBITDA came in at $49 million, below analyst expectations of approximately $54 million, pointing to ongoing pressure on margins.

Retail continues to anchor performance. The company generated $172 million in retail revenue, up both sequentially and year over year, while wholesale declined to $79 million, reflecting increased competition and promotional activity.

Despite that pressure, Verano maintained a gross margin near 48%, reinforcing its position as one of the more efficient large U.S. operators.

Management expects margins to remain relatively stable in the near term, with improvement anticipated in the second half of 2026 as pricing stabilizes and operational efficiencies scale.

The company is also positioning for regulatory upside. Verano secured a $195 million credit facility, announced a $20 million share repurchase program, and continues preparing for potential uplisting and Schedule III rescheduling.

“Given business performance and the transformative Schedule III medical cannabis designation, we believe the share repurchase authorization provides Verano further optionality to deploy capital in pursuit of growth initiatives,” said George Archos, Verano Chairman and Chief Executive Officer. “The share repurchase authorization offers Verano another strategic outlet to unlock value for the Company and our shareholders, including strengthening the balance sheet and accretive M&A opportunities.”

The buyback authorization alone covers up to 5% of shares outstanding, giving the company flexibility to deploy capital across multiple priorities.

Category positioning is another strength. Verano holds top-tier national rankings across product categories and is expanding into faster-growing segments such as pre-rolls and vape, aligning with broader market trends identified by Zuanic & Associates.

SNDL: Weak Demand, Strong Balance Sheet

SNDL’s results tell a different story.

The company reported $195.9 million in revenue, down 4.4% year over year. Gross profit fell 6.8%, and free cash flow turned negative at $7.6 million.

Cannabis operations were the weakest segment, with revenue declining 14.2% and margins compressing significantly (from 26.8% to 19.7%) due to lower production volumes, inventory adjustments, and softer business-to-business demand. The company also reported a net loss of $9.9 million for the quarter, reflecting continued pressure across its operating segments.

Those results align with broader market trends. According to Zuanic & Associates, the Canadian recreational cannabis market grew just 1.9% year over year in the first quarter, reflecting a low-growth environment that continues to weigh on operators. SNDL holds roughly 3.1% of the Canadian adult-use market, ranking among the top 10 operators but without a dominant position.

Where SNDL stands out is its balance sheet.

The company ended the quarter with $213.4 million in unrestricted cash and no debt, alongside a broader investment portfolio valued at more than $600 million.

That liquidity provides flexibility in a market where many competitors remain capital-constrained. Management reported that it is already deploying that advantage through share buybacks, cost optimization initiatives expected to generate $20 million in incremental operating income, and strategic investments through its SunStream platform.

Rescheduling could further enhance that positioning. SNDL’s exposure to U.S. cannabis credit markets through SunStream means improvements in industry fundamentals could directly impact the value of its investment portfolio.